Dr. Reddy's Laboratories Limited Financials

Market Capitalization $12.56 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	19.09
Forward PE	17.33
Price to Sales TTM	$0.04
Price to Book MRQ	$0.04
Enterprise to Revenue	0.02
Enterprise to EBITDA	0.06

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-03-31
Profit Margin	17.37%
Operating Margin	20.40%
Return on Assets TTM	10.37%
Return on Equity TTM	18.53%

Income Statement

Revenue TTM	$3,812,287,401
Revenue per Share TTM	$65.27
Quarterly Revenue Growth	20.10%
Gross Profit TTM	$2,230,071,319
EBITDA	$91,151,000,000
Net Income to Common TTM	$662,177,591
Diluted EPS TTM	$0.79
Quarterly Earnings Growth YoY	21.90%

Balance Sheet

Total Cash MRQ	$678,151,134
Total Cash per Share MRQ	$69.60
Total Debt MRQ	$
Total Debt to Equity MRQ	13.87
Current Ratio MRQ	1.92
Book Value per Share MRQ	$400.71

Cash Flow

Operating Cash Flow TTM	$543,710,743
Levered Free Cash Flow TTM	$139,596,103

RDY Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	832,003,105
Float Shares	595,031,981
Avg 10 Volume	1,361,820
Avg 30 Volume	None
Shares Short	12,466,072
Short Ratio	7.61
Short % of Shares	2.91%
% Held by Insiders	0.00%
% Held by Institutions	13.85%

Stock Price Summary

Beta	0.39
Fifty Two Week Low	$12.26
Fifty Two Week High	$16.89
Fifty Two Week Change	-3.50%
Day 50 MA	$14.66
Day 200 MA	$14.47

Dividends and Splits

Forward Annual Dividend Rate	$1.92
Forward Annual Dividend Yield	12.71%
Trailing Annual Dividend Rate	$0.48
Trailing Annual Dividend Yield	3.18%
Payout Ratio	11.77%
Dividend Date	2024-08-12
Ex Dividend Date	2024-07-30
Last Split Factor
Last Split Date	2024-11-05